Cramer: Don't judge biotech Moderna on stock's post-IPO drop

In this video

Share

Cramer: Don't judge biotech Moderna on stock's post-IPO drop

Jim Cramer says there's more to Wall Street newcomer Moderna than the action in the biotechnology company's stock.
01:13
Mon, Dec 10 20186:49 PM EST